---
figid: PMC4082184__nihms588374f2
figtitle: 'Turning Off AKT: PHLPP as a Drug Target'
organisms:
- Drosophila melanogaster
- Caenorhabditis elegans
- Bilateria
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Saccharomyces cerevisiae
- Euteleostomi
pmcid: PMC4082184
filename: nihms588374f2.jpg
figlink: /pmc/articles/PMC4082184/figure/F2/
number: F2
caption: 'PHLPP (center) directly dephosphorylates and inactivates AKT, PKC, and S6K,
  at their hydrophobic phosphorylation motif (green circle) thus opposing cell survival
  and growth signals, and directly dephosphorylates and activates Mst1 at an inhibitory
  site (red circle), thus promoting pro-apoptotic signals. Indicated are two negative
  feedback loops which control the steady-state levels of PHLPP: high AKT activity
  up regulates PHLPP levels by suppressing GSK-3-dependent degradation, and high S6K
  activity up regulates PHLPP expression. Note that targeting the PI3 kinase pathway
  within these feedback loops will have the consequence of decreasing PHLPP levels,
  thus promoting pro-survival pathways mediated by PKC and inhibiting pro-apoptotic
  pathways mediated by Mst1. The lipid phosphatase PTEN opposes the lipid kinase phosphatidylinositol
  3 kinase (PI3K) by dephosphorylating PIP3 and the lipid kinase DG kinase opposes
  phospholipase C by phosphorylating DG. Scaffolds play an essential role in controlling
  substrate specificity of PHLPP and are indicated in grey. Also shown is the negative
  feedback loop from S6K to the scaffold IRS-1, which dampens PI3K activation and
  hence AKT activation (see  also). Inset shows conserved domain structure of mammalian
  PHLPP family members showing PH domain (cyan), Leucine-rich repeats (LRR; orange),
  PP2C domain (green), and C-terminal PDZ-binding motif (pink); PHLPP1β and PHLPP2
  also have a predicted RA domain preceding the PH domain (not shown).'
papertitle: 'Turning Off AKT: PHLPP as a Drug Target.'
reftext: Alexandra C. Newton, et al. Annu Rev Pharmacol Toxicol. ;54:537-558.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.968378
figid_alias: PMC4082184__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC4082184__F2
ndex: 615275e9-decc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4082184__nihms588374f2.html
  '@type': Dataset
  description: 'PHLPP (center) directly dephosphorylates and inactivates AKT, PKC,
    and S6K, at their hydrophobic phosphorylation motif (green circle) thus opposing
    cell survival and growth signals, and directly dephosphorylates and activates
    Mst1 at an inhibitory site (red circle), thus promoting pro-apoptotic signals.
    Indicated are two negative feedback loops which control the steady-state levels
    of PHLPP: high AKT activity up regulates PHLPP levels by suppressing GSK-3-dependent
    degradation, and high S6K activity up regulates PHLPP expression. Note that targeting
    the PI3 kinase pathway within these feedback loops will have the consequence of
    decreasing PHLPP levels, thus promoting pro-survival pathways mediated by PKC
    and inhibiting pro-apoptotic pathways mediated by Mst1. The lipid phosphatase
    PTEN opposes the lipid kinase phosphatidylinositol 3 kinase (PI3K) by dephosphorylating
    PIP3 and the lipid kinase DG kinase opposes phospholipase C by phosphorylating
    DG. Scaffolds play an essential role in controlling substrate specificity of PHLPP
    and are indicated in grey. Also shown is the negative feedback loop from S6K to
    the scaffold IRS-1, which dampens PI3K activation and hence AKT activation (see  also).
    Inset shows conserved domain structure of mammalian PHLPP family members showing
    PH domain (cyan), Leucine-rich repeats (LRR; orange), PP2C domain (green), and
    C-terminal PDZ-binding motif (pink); PHLPP1β and PHLPP2 also have a predicted
    RA domain preceding the PH domain (not shown).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRR
  - Pp2C1
  - CG17598
  - CG7115
  - CG10376
  - Phlpp
  - Ppm1
  - CG17746
  - Tie
  - Ras85D
  - InR
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - sgg
  - Pten
  - Akt
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Dg
  - AP-1gamma
  - norpA
  - sl
  - Plc21C
  - Crtc
  - Oamb
  - S6k
  - Mst57Dc
  - Mst57Db
  - Mst57Da
  - PHLPP1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IRS1
  - GSK3A
  - GSK3B
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - MTOR
  - RPTOR
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - RPS6KB1
  - MST1
  - STK4
  - Phlpp1
  - Pik3cg
  - Irs1
  - Akt1
  - Prkcg
  - Tas2r134
  - Rxfp2
  - Mst1
  - Cancer
---
